版本:
中国

BRIEF-Nativis enters into licensing agreement for Glioblastoma Multiforme in Japan

April 4 Teijin Ltd

* Nativis enters into exclusive licensing agreement for Glioblastoma Multiforme in Japan

* Under terms of agreement, Teijin will receive an exclusive license to Nativis Voyager System for indication of GBM in Japan

* Co to receive an undisclosed upfront payment, payments based on achievement of specific milestones, royalties on sales of product in Japan

* Co, Teijin anticipate to continue discussions for potential licensing opportunities of Nativis ULRFE technology for other indications in Japan Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐